In July 1, 2006 the Department of Urologic Sciences became a reality in the UBC Faculty of Medicine. This milestone represents an opportunity: to develop programmes of excellence in key areas of urology with collaborations across departments, faculties, schools and industrial partners which, in conjunction with translational initiatives, will promote congruent progress on both the academic and clinical care delivery trajectories. A history of the leadership in the Department of Urologic Sciences (and the Division of Urology prior to 2006) and a list of the Urology Resident Alumni can be found on this site.

The UBC Department of Urologic Sciences has three full professors, a UBC Distinguished University Scholar, a BC Leadership Chair in prostate research (to support the research of Dr Martin Gleave), thirteen PhD research scientists and eight members who are actively, and successfully, pursuing careers as surgeon-scientists. Our expertise ranges from molecular biology to psycho-social research, pharmacokinetics, cell signaling, genomics, proteomics, laser energy, infrared diagnostics and MRI physics.

Our educational programs are strong and comprehensive. The 15 residents in the UBC urology program come from medical schools across the country. They routinely score very well on annual Urology In-Service exams (always above North American average, and often above the 90th percentile) and our graduates have a superb pass rate on the Royal College exam. The Prostate Centre is also a funded National Cancer Institute of Canada training centre and our faculty have supervised, or co-supervised, Masters and PhD students from around the world. We plan to develop a significant Graduate training curriculum to provide state of the art education of PhD and Masters students within the construct of a formal Faculty of Medicine Translational Sciences Graduate Program.

A highlight in the development of our pediatrics program as well as our postgraduate education, was the recruitment of Dr Andrew MacNeily. He has assembled and leads a first class team at Children’s Hospital, including Drs Kourosh Afshar and John Masterson. Collectively, they are as strong a teaching unit as any urology group in the country.

We recently opened the doors of a sophisticated Bladder Care Centre, under the academic guidance of Dr. Lynn Stothers whose team has had exciting success in their study of cranberry in the prevention and treatment of bladder disorders, non-invasive new technologies (Near Infra Red Spectroscopy or NIRS) to study bladder function and voiding dysfunction in diabetics. The Department is developing several more foci of special interest. Recent recruitments of Ryan Paterson, Joel Teichman, Ben Chew and Chris Nguan offer us the opportunity to reach the highest standards in laparoscopy/robotics/transplantation and stones/biophotonics/laser science/nanotechnology.

Our strong clinical faculty (26 members) has facilitated the development of a successful clinical and translational research unit, the foundation of the recently acquired Canada Foundation for Innovation (CFI) and Research Hospital Fund (RHF) grants which total nearly $40 million. Our clinical faculty members are proud to be a part of these great accomplishments, and this inclusiveness has strengthened our group, congruent with Osler’s fondest dream: “Clinical Faculty working in harmony as equals alongside their colleagues dedicated to research, each contributing ideas to the other’s task.”